Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EEG Changes After rTMS Stimulation

NCT: NCT07179224 · COMPLETED

NCT IDNCT07179224
StatusCOMPLETED
Start Date2025-09-17
Completion2025-10-29

Brief Summary

The goal of this clinical trial is to explore the brain's electrical reactivity, monitored using EEG, following the EXOMIND (BTL-699-2) stimulation across various stimulation locations. The main question it aims to answer is: What is the brain's cortical electrical reactivity, monitored using EEG, following the EXOMIND (BTL-699-2) stimulation across various stimulation locations? Participants will be asked to: * Undergo 1 treatment visit * Undergo electroencephalography (EEG) measurements * Complete Therapy Comfort Questionnaires

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑